Особливості клінічної картини, діагностики та лікування хвороби Іценка—Кушинга в дітей
Ключові слова:
хвороба Іценка—Кушинга, діти, кортизол, адренокортикотропний гормон, індекс маси тіла, швидкість ростуАнотація
Хвороба Іценка—Кушинга рідко трапляється в дітей. Від своєчасності встановлення діагнозу й лікування залежить ростовий прогноз, адекватність формування піку кісткової маси, розвиток метаболічних ускладнень захворювання. У статті представлено сучасні дані про особливості клінічної картини, діагностики та лікування хвороби Іценка—Кушинга в дитячому віці.Посилання
Acharya SV, Gopal RA, Lila A, Menon PS. Bone age and factors affecting skeletal maturation at diagnosis of paediatric Cushing’s disease. Pituitary. 2010;13(4):355-360.
Afshari A, Ardeshirpour Y, Lodish MB, Gourgari E. Facial Plethora: Modern Technology for Quantifying an Ancient Clinical Sign and Its Use in Cushing Syndrome. J Clin Endocrinol Metab. 2015;100(10):3928-3933.
Ahima RS, Harlan RE. Glucocorticoid receptors in LHRH neurons // Neuroendocrinology. 1992;56:845-850.
Auchus RJ. Adrenarche — Physiology, Biochemistry and Human Disease. Clin Endocrinol. (Oxf). 2004;60(3):288-296.
Bastos RV, Silva CM, Tagliarini JV. Endoscopic versus microscopic transsphenoidal surgery in the treatment of pituitary tumors: systematic review and meta-analysis of randomized and non-randomized controlled trials. Arch Endocrinol Metab. 2016;60(5):411-419.
Batista DL, Oldfield EH, Keil MF, Stratakis CA. Postoperative testing to predict recurrent Cushing disease in children. J Clin Endocrinol Metab. 2009;94(8):2757-2765.
Biller BM, Grossman AB, Stewart PM, Melmed S. Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab. 2008;93(7):2454-2462.
Buurman H, Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol. 2006;154(5):753-758.
Chan L et al. Long-term anterior pituitary function in patients with paediatric Cushing’s disease treated with pituitary radiotherapy. Eur J Endocrinol. 2007;156:477-482.
Davies JH, Storr HL, Davies K, Final adult height and body mass index after cure of paediatric Cushing’s disease. Clin Endocrinol. 2005;62(4):466-472.
Dupuis CC, Storr HL, Perry LA, Ho JT, Ahmed L. Abnormal puberty in paediatric Cushing›s disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations. Clin Endocrinol. (Oxf). 2007;66(6):838-843.
Estrada J, Garcia-Uria J, Lamas C, Alfaro J. The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab. 2001;86(12):5695-5699.
Guaraldi F, Storr HL, Ghizzoni L, Ghigo E. Paediatric pituitary adenomas: a decade of change. Horm Res Paediatr. 2014;81(3):145-155.
Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab. 2013;17(5):913-916.
Gursoy A, Dogruk UA, Ayturk S. Polycythemia as the first manifestation of Cushing’s disease. J Endocrinol Invest. 2006;29(8):742-744.
Katznelson L, Bogan JS, Trob JR. Biochemical assessment of Cushing’s disease in patients with corticotroph macroadenomas. J Clin Endocrinol Metabol. 1998;83:1619-1623.
Krieger DT. Сushing’s syndrome. — Berlin; New York: Springer-Verlag, 1982:142 p.
Leong GM, Mercado-Asis LB, Reynolds JC. The effect of Cushing‘s disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pair. J Clin Endocrinol Metab. 1996;81(5):1905-1911.
Lodish MB, Gourgari E, Sinaii N. Skeletal maturation in children with Cushing Syndrome is not consistently delayed: the role of corticotropin, obesity, and steroid hormones, and the effect of surgical cure. J Pediatr. 2014;164(4):801-806.
Lodish MB, Hui-Pin Hsiao HP, Sermbis А, Sinaii N, Effects of Cushing Disease on Bone Mineral Density in a Pediatric Population. J Pediatr. 2010;156(6):1001-1005.
Lodish M. Cushing’s syndrome in childhood: update on genetics, treatment, and outcomes. Curr Opin Endocrinol Diabetes Obes. 2015;22(1):48-54.
Lodish M, Dunn SV, Sinaii N et al. Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing’s disease. J Clin Endocrinol Metab. 2012;97(5):1483-1491.
Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990;112:352-364.
Magiakou MA, Chrousos GP. Cushing›s syndrome in children and adolescents: current diagnostic and therapeutic strategies. The Journal of Endocrinological Investigation. 2002;25(2):181-194.
Magiakou MA, Mastorakos G, Oldfield EH. Cushing›s Syndrome in Children and Adolescents — Presentation, Diagnosis, and Therapy. N Engl J Med. 1994;331:629-636.
Mazziotti G, Giustina A. Glucocorticoids and the regulation of growth hormone secretion. Nat Rev Endocrinol. 2013;9(5):265-276.
Paragliola RM, Locantore P, Pontecorvi A, Corsello SM. Pediatric Cushing’s Disease and Pituitary Incidentaloma: Is This a Real Challenge? Case Rep Endocrinol. 2014:851942.
Pereira AM, van Aken MO, van Dulken H, Schutte PJ. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing’s disease. J Clin Endocrinol Metab. 2003;88(12):5858-5864.
Peters CJ, Ahmed ML, Storr HL, Davies KM. Factors influencing skeletal maturation at diagnosis of paediatric Cushing›s disease. Horm Res. 2007;68(5):231-235.
Pivonello R, Leo М, Cozzolino А, Colao А. The Treatment of Cushing›s Disease. Endocr Rev. 2015;36(4):385-486.
Plowman PN. Pituitary radiotherapy: techniques and potential complications. Clinical Endocrine Oncology. Oxford, Blackwell Scientific. 1997:185-188.
Ragnarsson O, Johannsson G. Cushing›s syndrome: a structured short- and long-term management plan for patients in remission. Eur J Endocrinol. 2013;169(5):139-1152.
Savage MO, Chan LF, Afshar F. Advances in the Management of Paediatric Cushing’s Disease. Horm Res. 2008;69:327-333.
Savage MO, Storr HL. Pediatric Cushing’s disease: Management Issues Indian. J Endocrinol Metab. 2012;16(Suppl. 2):171-175.
Selby C. Sex hormone binding globulin: origin, function and clinical significance. Annals of Clinical Biochemistry. 1990;27:532-541.
Soyka LA, Fairfield WP, Klibanski A. Clinical review 117: Hormonal determinants and disorders of peak bone mass in children. J Clin Endocrinol Metab. 2000;85:3951-3963.
Sperling MA. Pediatric Endocrinology. — 4th ed. — New Jork: Alan R. Liss, 2014:1080.
Storr HL, Drake WM, Evanson J, Matson M. Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing›s disease. Clin Endocrinol. (Oxf). 2014;80(2):270-276.
Storr HL, Savage MO. Management of Endocrine Disease: Paediatric Cushing’s disease. Eur J Endocrinol. 2015;173(1):35-45.
Storr HL, Alexandraki KI. Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing’s disease. Eur J Endocrinol. 2011;164(5):667-674.
Sulentic P, Grossman A. Cushing’s Syndrome. Endotext. [Internet]. — Last Update: July 17, 2017.
Thoren M. et al. Treatment of Cushing’s disease in childhood and adolescence by stereotactic pituitary irradiation. Acta Paediatr Scand. 1986;75:388-395.
Utz A, Biller B. The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing’s syndrome. Arq Bras Endocrinol Metab. 2007;51:1329-1338.
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest. 1998;102:274-282.
Yanovski JA et al. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing›s syndrome from pseudo-Cushing›s states. JAMA. 1993;269(17):2232-2238.
